Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cazzola

Showing results (101-110 of 802) with videos related to

Pageof 81
Sort By:
Expert Review of Respiratory Medicine|September 30, 2011
Inhibiting or blocking LIGHT, a TNF superfamily member, for treating airway remodelingMario Cazzola, Maria Gabriella Matera
Expert Review of Respiratory Medicine|March 30, 2012
IL-17 in chronic obstructive pulmonary diseaseMario Cazzola, Maria Gabriella Matera
Handbook of Experimental Pharmacology|October 27, 2016
Fixed-Dose Combination InhalersMario Cazzola, Maria Gabriella Matera
International Journal of Chronic Obstructive Pulmonary Disease|November 30, 2007
The role of combination therapy with corticosteroids and long-acting beta2-agonists in the prevention of exacerbations in COPDMario Cazzola, Nicola A Hanania
Respiratory Medicine|October 24, 2006
The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD: a pilot studyMario Cazzola, Maria Gabriella Matera
Respiratory Medicine|February 26, 2020
The effect of doxofylline in asthma and COPDMario Cazzola, Maria Gabriella Matera
Drugs|March 14, 2007
ultra-long-acting beta2-adrenoceptor agonists: an emerging therapeutic option for asthma and COPD?Maria Gabriella Matera, Mario Cazzola
Hematology. American Society of Hematology. Education Program|December 17, 2008
The role of JAK2 mutations in RARS and other MDSEva Hellström-Lindberg, Mario Cazzola
Therapeutic Advances in Respiratory Disease|January 7, 2009
Safety of long-acting beta2-agonists in the treatment of asthmaMario Cazzola, Maria Gabriella Matera
Therapeutic Advances in Respiratory Disease|January 7, 2009
Cough and asthma: the role of inhaled corticosteroids and beta2-agonistsMario Cazzola, Maria Gabriella Matera
Pageof 81

Showing results (101-110 of 802) with videos related to

Sort By:
Pageof 81
Expert Review of Respiratory Medicine|September 30, 2011
Inhibiting or blocking LIGHT, a TNF superfamily member, for treating airway remodelingMario Cazzola, Maria Gabriella Matera
Expert Review of Respiratory Medicine|March 30, 2012
IL-17 in chronic obstructive pulmonary diseaseMario Cazzola, Maria Gabriella Matera
Handbook of Experimental Pharmacology|October 27, 2016
Fixed-Dose Combination InhalersMario Cazzola, Maria Gabriella Matera
International Journal of Chronic Obstructive Pulmonary Disease|November 30, 2007
The role of combination therapy with corticosteroids and long-acting beta2-agonists in the prevention of exacerbations in COPDMario Cazzola, Nicola A Hanania
Respiratory Medicine|October 24, 2006
The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD: a pilot studyMario Cazzola, Maria Gabriella Matera
Respiratory Medicine|February 26, 2020
The effect of doxofylline in asthma and COPDMario Cazzola, Maria Gabriella Matera
Drugs|March 14, 2007
ultra-long-acting beta2-adrenoceptor agonists: an emerging therapeutic option for asthma and COPD?Maria Gabriella Matera, Mario Cazzola
Hematology. American Society of Hematology. Education Program|December 17, 2008
The role of JAK2 mutations in RARS and other MDSEva Hellström-Lindberg, Mario Cazzola
Therapeutic Advances in Respiratory Disease|January 7, 2009
Safety of long-acting beta2-agonists in the treatment of asthmaMario Cazzola, Maria Gabriella Matera
Therapeutic Advances in Respiratory Disease|January 7, 2009
Cough and asthma: the role of inhaled corticosteroids and beta2-agonistsMario Cazzola, Maria Gabriella Matera
Pageof 81